Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

BlackRock, Inc. (BLK.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-04-15NaN915.00Buy
2022-04-18680.00870.00Buy
2022-05-09605.56825.00Buy
2022-07-10619.56718.00Buy
2022-07-18597.53700.00Buy
2022-10-10545.54585.00Neutral
2023-01-09752.99775.00Neutral
2023-04-11669.68715.00Neutral
2023-04-14691.33730.00Neutral
2023-07-10696.17727.00Neutral
2023-07-23751.21780.00Neutral
2023-10-10641.95720.00Neutral
2024-01-09794.52818.00Neutral
2024-04-11785.96850.00Neutral
2024-04-19749.98842.00Neutral
2024-07-09802.28837.00Neutral
2024-07-22843.24840.00Neutral
2024-10-08949.07960.00Neutral
2025-01-14963.171017.00Neutral
2025-01-201004.961045.00Neutral
2025-04-10858.781010.00Neutral
2025-04-15888.44980.00Neutral
2025-05-09923.44-No Rating

Disclosures

  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • BlackRock Inc owns 5% or more of a class of UBS Group AG's common equity securities.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.